Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Alpharadin

- PMLiVE

NICE heart attack recommendation for Xarelto

Bayer drug on course for another blood clot indication in England and Wales

- PMLiVE

Xarelto gets new atrial fibrillation label in Europe

First oral anticoagulant to gain EU approval in indication

- PMLiVE

Bayer names head of pharma comms in US

Steven Immergut joins from the US FDA

- PMLiVE

Germany’s IQWiG delivers bad news for Bayer’s Eylea

Says drug provides no additional benefit over Novartis’ rival Lucentis in eye condition

Bayer symbol

Bayer puts research at heart of business growth

Says R&D-to-sales ratio will increase

- PMLiVE

Bayer photo contest to raise awareness of blood clot

Public invited to submit photos that take their breath away

- PMLiVE

Eylea’s UK launch earns Bayer PMEA success

Receives the Cello Health Award for Launch Excellence

Bayer symbol

Bayer completes takeover of Chinese OTC company

Expands consumer health presence with Dihon purchase

Bayer symbol

Bayer CEO Dekkers points to ‘outstanding’ pharma growth

On target to meet company’s annual expectations of €7.5bn

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

Pharma supports first World Thrombosis Day

Aims to raise awareness of the blood clot condition

- PMLiVE

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links